These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3004198)

  • 21. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
    Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
    Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
    Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy.
    Frazer IH; Sarngadharan MG; Mackay IR; Gallo RC
    Med J Aust; 1984 Sep; 141(5):274-6. PubMed ID: 6088957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
    Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTLV-I-specific antibody in AIDS patients and others at risk.
    Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH
    Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphadenopathy and antibodies to HTLV-III in homosexual men. Clinical, laboratory and epidemiological features.
    Bienzle U; Guggenmoos-Holzmann I; Zwingenberger K; Thommsen R; Ritter K; Uy A; Bayer H; Schneider J; Hunsmann G; Coester CH
    Klin Wochenschr; 1985 Jul; 63(13):597-602. PubMed ID: 2993734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune impairments and antibodies to HTLVIII/LAV in asymptomatic male homosexuals in Israel: relevance to the risk of acquired immune deficiency syndrome (AIDS).
    Bentwich Z; Saxinger C; Ben-Ishay Z; Burstein R; Berner Y; Pecht M; Trainin N; Levin S; Handzel ZT
    J Clin Immunol; 1987 Sep; 7(5):376-80. PubMed ID: 2443528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.
    Hunsmann G; Schneider J; Bayer H; Kurth R; Werner A; Brede HD; Erfle V; Mellert W; Brodt HR; Bergmann L
    Klin Wochenschr; 1985 Mar; 63(5):233-5. PubMed ID: 2985862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LAV/HTLV-III neutralizing antibodies in the sera of patients with AIDS, lymphadenopathy syndrome and asymptomatic seropositive individuals.
    Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Chieco-Bianchi L
    Tumori; 1986 Jun; 72(3):219-24. PubMed ID: 3016957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.
    Manca N; Caruso A; Bonfanti C; Savoldi E; Li Vigni R; Pirali F; Sapelli PL; Turano A
    Eur J Epidemiol; 1989 Mar; 5(1):37-41. PubMed ID: 2707393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area.
    Rasheed S; Norman GL; Gill PS; Meyer PR; Cheng L; Levine AM
    Virology; 1986 Apr; 150(1):1-9. PubMed ID: 3006329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
    Harada S; Purtilo DT; Koyanagi Y; Yamamoto N
    Microbiol Immunol; 1986; 30(6):533-44. PubMed ID: 3018457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome.
    Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ
    Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-lymphotropic virus type III infection in previously immunocompromised hosts.
    Groopman JE; Hammer SM; Sallan SE; Allan JD
    J Clin Oncol; 1986 Apr; 4(4):540-3. PubMed ID: 3007685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.
    Groopman JE; Salahuddin SZ; Sarngadharan MG; Markham PD; Gonda M; Sliski A; Gallo RC
    Science; 1984 Oct; 226(4673):447-9. PubMed ID: 6093247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of haematological screening for AIDS in an at risk population.
    Weber JN; Walker D; Engelkins H; Bain B; Harris JR
    Genitourin Med; 1985 Oct; 61(5):325-9. PubMed ID: 2995238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.